• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病患者不良病程的相关因素:一项观察性回顾性研究

Related Factors for Unfavorable Disease Course in Patients with Crohn's Disease: An Observational Retrospective Study.

作者信息

Han Dong Yoon, You Myung-Won, Oh Chi Hyuk, Park Seong Jin

机构信息

Department of Radiology, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.

Department of Internal Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.

出版信息

Diagnostics (Basel). 2023 Jan 11;13(2):273. doi: 10.3390/diagnostics13020273.

DOI:10.3390/diagnostics13020273
PMID:36673083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9857483/
Abstract

Background: Crohn’s disease (CD) manifests a heterogeneous clinical spectrum and disease course, and it is challenging to predict the disease outcome based on initial presentation. Objective: To analyze the long-term disease course and factors leading to poor prognosis of CD. Methods: In total, 112 patients with CD who were initially diagnosed and treated at our institution from January 2009 to August 2020 were included. We analyzed their clinical data, disease characteristics according to the Montreal classification, and the endoscopic and computed tomography (CT) examinations at the initial visit and at 2-year, 5-year, and last follow ups. We categorized the disease course into the following four categories: remission, stable, chronic refractory, and chronic relapsing. Significant factors associated with a poorer prognosis were analyzed. Results: The median follow-up period was 107 (range, 61−139) months. Complicated disease behavior increased slightly over the follow-up period (20.5% to 26.2%). An unfavorable disease course was defined as chronic refractory (19.6%) and relapsing (16.1%) courses. The 2-year disease characteristics were significant factors for unfavorable disease course, and the combination of 2-year perianal disease and 2-year moderate-to-severe CT activity could predict unfavorable disease course with the highest accuracy (0.722; area under the curve: 0.768; p < 0.0001). Conclusions: One-third of the patients with CD showed an unfavorable disease course (35.7%), and 2-year disease characteristics were significant factors for an unfavorable disease course.

摘要

背景

克罗恩病(CD)表现出异质性的临床谱和病程,基于初始表现预测疾病结局具有挑战性。目的:分析CD的长期病程及导致预后不良的因素。方法:纳入2009年1月至2020年8月在本机构初诊并接受治疗的112例CD患者。分析其临床资料、根据蒙特利尔分类的疾病特征,以及初诊时、2年、5年和末次随访时的内镜及计算机断层扫描(CT)检查结果。将病程分为以下四类:缓解、稳定、慢性难治性和慢性复发性。分析与预后较差相关的显著因素。结果:中位随访期为107(范围61 - 139)个月。随访期间复杂疾病行为略有增加(从20.5%至26.2%)。不良病程定义为慢性难治性(19.6%)和复发性(16.1%)病程。2年时的疾病特征是不良病程的显著因素,2年肛周疾病和2年中重度CT活动度的组合预测不良病程的准确性最高(0.722;曲线下面积:0.768;p < 0.0001)。结论:三分之一的CD患者表现出不良病程(35.7%),2年时的疾病特征是不良病程的显著因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/44f41143eb0b/diagnostics-13-00273-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/c27f62135401/diagnostics-13-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/938ec7f3bd6a/diagnostics-13-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/42cc820438bd/diagnostics-13-00273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/3bec56e19dbb/diagnostics-13-00273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/44f41143eb0b/diagnostics-13-00273-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/c27f62135401/diagnostics-13-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/938ec7f3bd6a/diagnostics-13-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/42cc820438bd/diagnostics-13-00273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/3bec56e19dbb/diagnostics-13-00273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0936/9857483/44f41143eb0b/diagnostics-13-00273-g005.jpg

相似文献

1
Related Factors for Unfavorable Disease Course in Patients with Crohn's Disease: An Observational Retrospective Study.克罗恩病患者不良病程的相关因素:一项观察性回顾性研究
Diagnostics (Basel). 2023 Jan 11;13(2):273. doi: 10.3390/diagnostics13020273.
2
A comprehensive review and update on Crohn's disease.克罗恩病的全面综述与更新
Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18.
3
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
4
Long-term Disease Course of Crohn's Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors.克罗恩病的长期病程:病变部位、表型、活动度的变化及预测因素。
Gut Liver. 2022 Mar 15;16(2):157-170. doi: 10.5009/gnl210118.
5
Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn's Disease.疾病活动簇与儿童克罗恩病临床病程的早期危险因素。
Inflamm Bowel Dis. 2024 Nov 4;30(11):1983-1991. doi: 10.1093/ibd/izad275.
6
Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn's disease?哪些磁共振成像特征与肛周瘘管型克罗恩病的治疗反应相关?
Abdom Radiol (NY). 2024 Aug;49(8):2913-2920. doi: 10.1007/s00261-024-04238-3. Epub 2024 Mar 21.
7
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
8
Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn's disease under infliximab therapy.英夫利昔单抗谷浓度联合炎症生物标志物预测英夫利昔单抗治疗克罗恩病的长期内镜结局。
World J Gastroenterol. 2022 Jun 21;28(23):2582-2596. doi: 10.3748/wjg.v28.i23.2582.
9
Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.优特克单抗治疗克罗恩病的长期真实世界数据:斯德哥尔摩优特克单抗研究
Therap Adv Gastroenterol. 2024 Apr 23;17:17562848241242700. doi: 10.1177/17562848241242700. eCollection 2024.
10
[Anti-TNF therapy in treatment of luminal Crohn's disease].[抗TNF治疗在腔内型克罗恩病治疗中的应用]
Acta Med Croatica. 2013 Apr;67(2):179-89.

引用本文的文献

1
Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta-Analysis.成人克罗恩病的生物疗法和小分子药物:系统评价与网状Meta分析
Pharmacotherapy. 2025 Sep;45(9):587-599. doi: 10.1002/phar.70049. Epub 2025 Aug 7.

本文引用的文献

1
Correlation Between Crohn's Disease Activity and Serum Selenium Concentration.克罗恩病活动与血清硒浓度的相关性。
Clin Ther. 2022 May;44(5):736-743.e3. doi: 10.1016/j.clinthera.2022.03.005. Epub 2022 Apr 1.
2
Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.斯里兰卡炎症性肠病的表型变化、早期临床病程及临床预测因素:一项基于三级医疗的回顾性多中心研究
BMC Gastroenterol. 2021 Feb 16;21(1):71. doi: 10.1186/s12876-021-01644-5.
3
Clinical outcomes and long-term prognosis of perianal Crohn's disease in an Asian population.
亚洲人群肛周克罗恩病的临床结局及长期预后
J Gastroenterol Hepatol. 2021 Jun;36(6):1571-1579. doi: 10.1111/jgh.15308. Epub 2020 Nov 15.
4
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.儿童克罗恩病的医学管理:欧洲克罗恩病和结肠炎组织(ECCO)-欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)指南更新
J Crohns Colitis. 2020 Oct 7. doi: 10.1093/ecco-jcc/jjaa161.
5
Clinical updates on perianal fistulas in Crohn's disease.克罗恩病肛周瘘管的临床新进展。
Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):597-605. doi: 10.1080/17474124.2018.1480936. Epub 2018 Jun 4.
6
ACG Clinical Guideline: Management of Crohn's Disease in Adults.ACG 临床指南:成人克罗恩病的管理。
Am J Gastroenterol. 2018 Apr;113(4):481-517. doi: 10.1038/ajg.2018.27. Epub 2018 Mar 27.
7
Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.《小肠克罗恩病患者计算机断层扫描和磁共振肠造影评估、解读和应用的共识建议》。
Radiology. 2018 Mar;286(3):776-799. doi: 10.1148/radiol.2018171737. Epub 2018 Jan 10.
8
A comprehensive review and update on Crohn's disease.克罗恩病的全面综述与更新
Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18.
9
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.乌司奴单抗治疗中重度克罗恩病的临床、内镜及影像学反应的长期维持:一项多中心队列研究的真实世界经验
Inflamm Bowel Dis. 2017 May;23(5):833-839. doi: 10.1097/MIB.0000000000001074.
10
Changes of Crohn's disease phenotype over time.克罗恩病表型随时间的变化。
Tunis Med. 2016 Jun;94(6):167-170.